Datadog heads into the first week of July having done something notable: it rallied 18% in a single week to close at $260.36, lapping nearly the entire analyst target consensus in a matter of days.
The catalyst is the May earnings print that keeps reverberating. The stock gapped 39% higher on May 7 and held almost all of that gain through the five-day window, a +41% move. That kind of post-earnings momentum does not fade quietly, and the short-interest data tells the story of positioning adjusting to a new reality. Bears have been retreating — short interest has dropped roughly 4.3% over the past month to sit at 4.3% of the free float, with a further 2.5% reduction in the final session of June alone. That level is not threatening by any measure, and the borrow market confirms the lack of conviction: availability is running at a striking 5,767% — meaning roughly 58 shares remain lendable for every one currently borrowed. Borrow costs have picked up week-on-week, rising 77% to 0.55%, but they are starting from such a low base that the absolute level remains trivial. The lending market describes a name where short sellers are light and getting lighter, not one facing squeeze pressure.
Options traders have rotated toward a more constructive stance over the past two weeks. The put/call ratio has eased to 0.79, below its 20-day average of 0.82 and well off the defensive readings above 0.90 that prevailed through most of June. The move is directionally consistent with the price action — hedging demand has dropped as the stock climbed. At 0.79, the ratio is approaching the lower end of its 52-week range (0.62), though it is not yet at an extreme that would suggest complacency.
The Street's response to the May print has been a wave of target upgrades that is still working through the system. Truist Securities went furthest, lifting its rating from Hold to Buy and taking its target from $190 to $300. Citigroup and Scotiabank both raised targets into the $265–$275 range. Even so, with the stock now trading at $260, the consensus mean target of $242 is already below the current price — a rare setup where the market has outrun the Street's collective conviction. Forward EPS momentum is the bull's anchor: the 12-month forward EPS estimate is showing year-on-year expansion that ranks in the 95th percentile of the universe. The PE multiple is rich at 84x and EV/EBITDA runs near 63x, but bulls argue that the AI-driven observability buildout justifies premium pricing as enterprises deploy more agent-based workloads that require deeper monitoring. Bears counter with the obvious: enterprise IT budget compression, hyperscaler tooling competition, and the risk that shorter cloud project cycles reduce the total addressable market for Datadog's depth of instrumentation.
Insider activity adds a mild counterpoint. Director Amit Agarwal sold approximately $4.4 million across multiple tranches on June 25, executing at prices around $215–$223 — well below where the stock closed the week. The Founder and CTO Alexis Le-Quoc sold a further $1.7 million on June 22. The 90-day net position across all insiders is modestly positive at $18.9 million in net value terms, but the recent individual sales are worth noting given their proximity to the rally. Neither transaction carries unusual significance on its own, and pre-arranged plans are common at this scale, but the pattern of insiders selling into strength at prices now below the current quote is a data point the market will note.
The next scheduled earnings event is August 6. Close cybersecurity and infrastructure peers moved sharply in the same direction this week — CRWD rose 12%, PANW gained 17%, and TENB surged 35% — suggesting a sector-wide re-rating rather than Datadog-specific alpha. Whether the stock can sustain its premium to the analyst consensus, or whether the Street races to catch up with fresh targets before August, is the tension worth watching as the summer sets in.
See the live data behind this article on ORTEX.
Open DDOG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.